The global insulin delivery devices market was valued at $8.8 billion in 2012 and is forecast to reach $13.8 billion by 2019, at a CAGR of 7%. Browse this report: http://mrr.cm/Zim

1. www.MarketResearchReports.com
Category : Medical Devices
All logos and Images mentioned on this slide belong to their respective owners.

2. www.MarketResearchReports.com
Introduction to Report
 Launch Date: April 4, 2014
 Number of Pages: 121
 Geography Coverage: Global
 Available Format: PDF
Price For Single User License: USD 3,500
Price For Site User License: USD 7,000
Price For Global User License: USD 10,500
Delivery Time: Within 24 Hours (During Working Days)

3. www.MarketResearchReports.com
About the Report
Insulin Delivery Devices Market to 2019 - Simplified Pump
Solutions and Low Cost Pens Represent Distinct Regional
Growth Drivers report looks at the market, competitive
landscape, and trends for the four insulin delivery devices
market segments: insulin pens, insulin pumps, insulin
syringes and traditional insulin pump accessories.
It provides comprehensive information on the key trends
affecting these segments, and key analytical content on
the market dynamics.

4. www.MarketResearchReports.com
Research Findings
The global insulin delivery devices market was valued at $8.8
billion in 2012 and is forecast to reach $13.8 billion by 2019, at a
CAGR of 7%.
Emerging economies such as India and China are expected to
grow at the fastest pace during the 2012-2019 forecast period.
The use of pre-filled cartridges eliminates the need for insulin
reservoirs and reduces the weight of the insulin pump by 25%.
Currently, the top two players, Medtronic and Animas
Corporation, account for 80% of insulin pump sales in the US.
Insulet Corporation, with its flagship insulin pump OmniPod,
holds about 15% of the market, while other small players such as
Tandem, Asante and Roche hold a combined market share of 5%.
The Research estimates, competitive conversions will account
for about 60% of the sales generated by new entrants such as
Insulet Corporation, Tandem Diagnostics and Asante in the
future. Patients who are new to insulin pump therapy will
contribute close to 40% of the sales generated by new entrants.

5. www.MarketResearchReports.com
Research Findings Continues…
The worldwide prevalence of diabetes in 2013 was 381.8
million, and this is projected to increase by 55% to 591.1 million
by 2035. It is also estimated that 175 million diabetics remain
undiagnosed, which accounts for 46% of all diabetics worldwide.
China had a diabetes prevalence of 98.4 million, followed by
India with 65.1 million and the US with 24.4 million.
At the current rate, diabetes prevalence in China is expected to
increase to 142.7 million by 2035, while in India it is expected to
rise to 109 million by 2035. In 2013, the US spent $239 billion on
diabetes, accounting for 36% of its healthcare expenditure, while
China, the country with the highest number of diabetics
globally, spent only $38 billion on diabetes, accounting for 7% of
its healthcare costs.

6. www.MarketResearchReports.com
Research Findings Continues…
The study showed that the annual cost of providing insulin
pumps was projected from $8.6 billion in 2012 to $15.1 billion by
2032. The annual cost of treatment for serious complications
from diabetes was projected from $8.8 billion in 2012 to $25.1
billion by 2032.
These are the direct costs related to the management of serious
complications from diabetes. Considering only the direct
costs, government investment in insulin pumps could save
$200,000 in 2012 and $10 billion by 2032.
Taking indirect costs into account, such as costs associated with
mortality and disability arising from diabetes, the net savings
will increase to $800,000 in 2012 and $10.8 billion by 2032.

7. www.MarketResearchReports.com
Report Coverage
Table of Contents
Introduction
Diabetes – Disease Overview
Diabetes – Epidemiology
Global Insulin Delivery Devices Market: Device Overview
Global Insulin Delivery Devices Market: Market
Characterization
Global Insulin Delivery Devices Market: Segment Analysis and
Forecasts
Global Insulin Delivery Devices Market: Country Analysis and
Forecasts
Global Insulin Delivery Devices Market: Reimbursement System
Global Insulin Delivery Devices Market: Competitive Landscape
Global Insulin Delivery Devices Market: Product Pipeline
Analysis
Global Insulin Delivery Devices Market: Consolidation
Landscape
Appendix

8. www.MarketResearchReports.com
Company Coverage
1. Novo Nordisk (Subsidiary of Novo A/S)
2. Sanofi
3. Eli Lilly
4. Medtronic
5. Becton, Dickinson and Company
6. Animas
7. F. Hoffmann-La Roche
8. Insulet
9. Asante Solutions
10. Abbott Laboratories
11. Ypsomed
12. Owen Mumford
13. Bioject Medical Technologies
14. Injex - Equidyne Systems
15. Antares Pharma
16. Tandem Diabetes Care
17. Tonghua Dongbao Pharmaceutical
18. Shanghai Fosun Pharmaceutical

9. www.MarketResearchReports.com
Custom Research:
 Are you an industry professional, entrepreneur,
venture capitalist, investors and organization, then let
us know your specific research requirements. Our goal
is to cater to your requirements be it for a custom
market research project, syndicated research report on
a specific market or industry sector, newsletter creation,
case study development or anything else related to
marketing research.
For Any Customization Related query Visit IdeaCenter @
http://www.marketresearchreports.com/idea-center

10. www.MarketResearchReports.com
How To Buy This Report?
Visit following URL to see Table of Content and
purchase this publication:
http://mrr.cm/Zim
About Market Research Reports, Inc.
Market Research Reports provides a customized set
of reports from reputed Publishers, built on the
intelligence available within organizations and
leverages on our motto of “Intelligence Redefined”.
Contact : Amitava Sen
Email : info@marketresearchreports.com
Phone: +1 302-703-7787 (USA) +91-8762746600 (India)